Cadrenal Therapeutics, Inc. (CVKD) IPO - S-1 Filing, Stock & Insider Activity
Cadrenal Therapeutics, Inc. IPO - Status & S-1 Filing
- Ticker: CVKD
- Status: Registered - S-1 filed with the SEC
- S-1 filed: 2025-12-29
- Exchange: NASDAQ
- Expected price range: not yet disclosed (set in a later S-1/A or pricing amendment)
- Shares offered: 428,227
- SEC CIK: 0001937993 · View the S-1 on SEC EDGAR →
Track every registration update on the InsiderAlpha IPO tracker.
Last SEC filing
Cadrenal Therapeutics, Inc. (CVKD) has filed 10 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-02. Insider sales over the same period: 22 transactions worth $388K. 8 Form 8-K material event filings were reported by CVKD in the last 90 days. 2 Form 144 notices of proposed sale were filed for CVKD stock. InsiderAlpha tracks every CVKD SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About Cadrenal Therapeutics, Inc. (CVKD)
Cadrenal Therapeutics, Inc. trades under the ticker CVKD. InsiderAlpha tracks 24 primary SEC Form 4 filings from 3 reporting insiders for CVKD since 2025, sourced directly from SEC EDGAR.
| Sector | Health Care insider trading |
|---|---|
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
| SEC CIK | 0001937993 |
90-Day SEC Filing Activity
| Insider sales (90d) | 22 ($388K) |
|---|---|
| Form 4 filings (90d) | 10 |
| Form 8-K filings (90d) | 8 |
| Form 144 notices (90d) | 2 |
| Latest Form 4 filing | 2026-07-02 |
Recent CVKD Insider Transactions (Form 4)
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Quang X. Pham | Chairman and CEO | S - Open-market sale [10b5-1] | 7.4K | $3.03 | $22K | SEC | |
| Quang X. Pham | Chairman, CEO and Interim CFO | S - Open-market sale [10b5-1] | 9.0K | $3.05 | $28K | SEC | |
| Quang X. Pham | Chairman, CEO and Interim CFO | S - Open-market sale [10b5-1] | 2.1K | $3.00 | $6K | SEC | |
| Quang X. Pham | Chairman, CEO and Interim CFO | S - Open-market sale [10b5-1] | 2.3K | $3.20 | $7K | SEC | |
| Quang X. Pham | Chairman, CEO and Interim CFO | S - Open-market sale [10b5-1] | 9.2K | $3.55 | $33K | SEC | |
| Quang X. Pham | Chairman, CEO and Interim CFO | S - Open-market sale [10b5-1] | 513 | $3.16 | $2K | SEC | |
| Quang X. Pham | Chairman, CEO and Interim CFO | S - Open-market sale [10b5-1] | 3.6K | $3.18 | $11K | SEC | |
| Quang X. Pham | Chairman, CEO and Interim CFO | S - Open-market sale [10b5-1] | 3.7K | $3.58 | $13K | SEC | |
| Quang X. Pham | Chairman, CEO and Interim CFO | S - Open-market sale [10b5-1] | 13.0K | $3.94 | $51K | SEC | |
| Quang X. Pham | Chairman, CEO and Interim CFO | S - Open-market sale [10b5-1] | 1.5K | $4.12 | $6K | SEC | |
| Quang X. Pham | Chairman, CEO and Interim CFO | S - Open-market sale [10b5-1] | 3.5K | $4.21 | $15K | SEC | |
| Quang X. Pham | Chairman, CEO and Interim CFO | S - Open-market sale [10b5-1] | 13.0K | $4.06 | $53K | SEC | |
| Quang X. Pham | Chairman, CEO and Interim CFO | S - Open-market sale [10b5-1] | 5.9K | $4.38 | $26K | SEC | |
| Quang X. Pham | CEO and Chairman | S - Open-market sale [10b5-1] | 2.1K | $4.42 | $9K | SEC | |
| Quang X. Pham | CEO and Chairman | S - Open-market sale [10b5-1] | 3.9K | $4.41 | $17K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Cadrenal Therapeutics, Inc. (CVKD). Updated in real time as new filings are submitted to the SEC.
Most-Active CVKD Insiders - Last 90 Days
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Quang X. Pham | 22 | $388K |
Recent CVKD Form 8-K Material Events
- - Item 7.01, 8.01, 9.01 [SEC]
- - Item 5.02, 9.01 [SEC]
- - Item 5.02, 9.01 [SEC]
- - Item 1.01, 3.02, 8.01, 9.01 [SEC]
- - Item 5.02, 9.01 [SEC]
Recent CVKD Form 144 Notices of Proposed Sale
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
Recent Insider Filings
- - Quang X. Pham (Chairman and CEO)
- - Quang X. Pham (Chairman, CEO and Interim CFO)
- - Quang X. Pham (Chairman, CEO and Interim CFO)
- - Quang X. Pham (Chairman, CEO and Interim CFO)
- - Quang X. Pham (Chairman, CEO and Interim CFO)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in CVKD insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
CVKD Insider Trading - FAQ
- What is the latest insider trade for CVKD?
- Cadrenal Therapeutics, Inc. (CVKD) had 10 insider filings in the last 90 days, with the most recent on 2026-07-02. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying CVKD stock?
- 0 insider purchases of CVKD were filed in the last 90 days.
- How many insiders are selling CVKD stock?
- 22 insider sales of CVKD were filed in the last 90 days, totaling $388K.
- Where can I see CVKD SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks CVKD Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $CVM CEL SCI CORP
- $DMAC DiaMedica Therapeutics Inc.
- $EDGM Edgemode, Inc.
- $ERNA Ernexa Therapeutics Inc.
- $ETNB 89bio, Inc.
- $EWTX Edgewise Therapeutics, Inc.
- $FBIO Fortress Biotech, Inc.
- $GNPX Genprex, Inc.
- $GOVX GeoVax Labs, Inc.
- $GRI GRI Bio, Inc.
Related Companies - Recent Insider Activity
- UNITED THERAPEUTICS Corp (UTHR)
- Liquidia Corp (LQDA)
- BeOne Medicines Ltd. (ONC)
- PERRIGO Co plc (PRGO)
- Processa Pharmaceuticals, Inc. (PCSA)
- Nuvalent, Inc. (NUVL)
- CYTOKINETICS INC (CYTK)
- Elanco Animal Health Inc (ELAN)
- Avalo Therapeutics, Inc. (AVTX)
- NATURES SUNSHINE PRODUCTS INC (NATR)
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live CVKD dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.